1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Trevi Therapeutics Inc (TRVI)
  7. Quote


Trevi Therapeutics Stock Price

-0.10 (-10.53%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 154,109
Bid Price 0.81
Ask Price 0.92
News -
Day High 0.99


52 Week Range


Day Low 0.881
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Trevi Therapeutics Inc TRVI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.10 -10.53% 0.85 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.99 0.881 0.99 0.8982 0.95
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
383 154,109 $ 0.9157272 $ 141,122 - 0.881 - 3.64
Last Trade Time Type Quantity Stock Price Currency
16:45:00 20 $ 0.90 USD


Draw Mode:

Trevi Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 21.97M 25.85M 8.36M $ - $ - -1.81 -0.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 55.66M 3.80%

more financials information »

Trevi Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TRVI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.99591.070.8810.970956977,910-0.1459-14.65%
1 Month1.201.240.8811.11385,880-0.35-29.17%
3 Months1.531.650.8811.33536,328-0.68-44.44%
6 Months2.142.500.8811.42285,095-1.29-60.28%
1 Year3.003.640.8811.74183,825-2.15-71.67%
3 Years9.5010.620.8812.83104,547-8.65-91.05%
5 Years9.5010.620.8812.83104,547-8.65-91.05%

Trevi Therapeutics Description

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. It is involved in developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, or IPF, and levodopa-induced dyskinesia, or LID, in patients with Parkinson's disease.

Your Recent History
Trevi Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.